[{"id":"4b1e2885-ae3f-433a-8a0a-828ebea2022b","acronym":"","url":"https://clinicaltrials.gov/study/NCT03448393","created_at":"2021-01-18T17:00:10.946Z","updated_at":"2024-07-02T16:34:37.765Z","phase":"Phase 1","brief_title":"CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies","source_id_and_acronym":"NCT03448393","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD19 • CD22","pipe":" | ","alterations":" CD19 expression • CD22 expression","tags":["CD19 • CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • CD22 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CD19/CD22 CAR T-cells • cyclophosphamide intravenous"],"overall_status":"Recruiting","enrollment":" Enrollment 140","initiation":"Initiation: 03/26/2018","start_date":" 03/26/2018","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/31/2040","study_completion_date":" 12/31/2040","last_update_posted":"2024-06-06"},{"id":"d478b0d6-30dd-47cf-b944-82d63c993fca","acronym":"","url":"https://clinicaltrials.gov/study/NCT04029038","created_at":"2021-01-18T19:46:36.486Z","updated_at":"2024-07-02T16:35:39.488Z","phase":"Phase 1/2","brief_title":"Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma","source_id_and_acronym":"NCT04029038","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" CD22","pipe":" | ","alterations":" CD22 positive","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD22 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CD19/CD22 CAR T-cells • cyclophosphamide intravenous"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 05/15/2019","start_date":" 05/15/2019","primary_txt":" Primary completion: 11/16/2022","primary_completion_date":" 11/16/2022","study_txt":" Completion: 11/16/2022","study_completion_date":" 11/16/2022","last_update_posted":"2023-08-21"}]